FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 93 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $22,802,000 | +126.1% | 605,300 | +2.1% | 0.06% | +133.3% |
| Q4 2020 | $10,085,000 | +395.8% | 592,900 | +37.0% | 0.03% | +350.0% |
| Q3 2020 | $2,034,000 | -18.2% | 432,700 | +6.2% | 0.01% | -14.3% |
| Q2 2020 | $2,486,000 | +163.1% | 407,500 | -2.1% | 0.01% | +75.0% |
| Q1 2020 | $945,000 | -43.3% | 416,400 | +14.6% | 0.00% | 0.0% |
| Q4 2019 | $1,668,000 | +114.7% | 363,400 | +81.2% | 0.00% | +100.0% |
| Q3 2019 | $777,000 | -30.8% | 200,600 | +7.7% | 0.00% | -33.3% |
| Q2 2019 | $1,123,000 | -44.9% | 186,300 | +22.5% | 0.00% | -40.0% |
| Q1 2019 | $2,038,000 | +17.7% | 152,100 | -18.3% | 0.01% | 0.0% |
| Q4 2018 | $1,731,000 | -42.3% | 186,100 | -13.6% | 0.01% | -28.6% |
| Q3 2018 | $3,000,000 | +4.9% | 215,500 | +19.1% | 0.01% | -12.5% |
| Q2 2018 | $2,860,000 | -15.0% | 180,900 | -7.7% | 0.01% | -11.1% |
| Q1 2018 | $3,366,000 | +141.5% | 195,900 | +208.0% | 0.01% | +125.0% |
| Q4 2017 | $1,394,000 | +354.1% | 63,600 | +748.0% | 0.00% | +300.0% |
| Q3 2017 | $307,000 | +32.3% | 7,500 | -2.6% | 0.00% | 0.0% |
| Q2 2017 | $232,000 | -48.2% | 7,700 | -37.9% | 0.00% | 0.0% |
| Q1 2017 | $448,000 | -23.5% | 12,400 | +6.0% | 0.00% | -50.0% |
| Q4 2016 | $586,000 | -75.4% | 11,700 | -74.2% | 0.00% | -80.0% |
| Q3 2016 | $2,383,000 | +724.6% | 45,400 | +548.6% | 0.01% | +900.0% |
| Q2 2016 | $289,000 | -67.5% | 7,000 | -68.0% | 0.00% | -80.0% |
| Q1 2016 | $890,000 | +315.9% | 21,900 | +154.7% | 0.01% | +150.0% |
| Q2 2015 | $214,000 | -33.5% | 8,600 | -39.0% | 0.00% | 0.0% |
| Q1 2015 | $322,000 | – | 14,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eventide Asset Management | 601,000 | $24,587,000 | 1.39% |
| HealthCor Management, L.P. | 1,010,930 | $41,357,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 86,500 | $3,535,000 | 1.38% |
| PURA VIDA INVESTMENTS, LLC | 75,000 | $3,068,000 | 0.90% |
| BB BIOTECH AG | 777,500 | $31,808,000 | 0.88% |
| AWM Investment Company, Inc. | 100,000 | $4,091,000 | 0.71% |
| Granite Point Capital Management, L.P. | 50,000 | $2,046,000 | 0.43% |
| Rock Springs Capital Management LP | 217,700 | $8,906,000 | 0.41% |
| Crestline Management, LP | 50,919 | $2,083,000 | 0.29% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,432,700 | $99,522,000 | 0.24% |